1. "Radiochemistry and Imaging Sciences Service"
  2. "Executive Committee, Center for Hematologic Malignancies"
Formats
  1. Journal Article (13)
  2. Meeting Abstract (10)
Groups
  1. Center for Hematologic Malignancies (23)
  2. Executive Committee, Center for Hematologic Malignancies (23)
  3. GSK Faculty (23)
  4. Radiochemistry and Imaging Sciences Service (23)
  5. Radiology, Department of (23)
  6. Department of Medicine (21)

More Groups

People
  1. Jason Lewis (18)
  2. Charles Sawyers (12)
  3. Michael Evans (9)
  4. Steven Larson (9)
  5. Jason Holland (6)
  6. Michael Doran (6)

More People

Years
  1. 2022 (2)
  2. 2020 (1)
  3. 2019 (1)
  4. 2018 (1)
  5. 2016 (2)
  6. 2015 (3)

More Years

Publications
  1. Cancer Research (4)
  2. Journal of Nuclear Medicine (4)
  3. Journal of Labelled Compounds and Radiopharmaceuticals (2)
  4. Nature (2)
  5. Biology of Blood and Marrow Transplantation (1)
  6. Cancer Cell (1)

More Publications

Publishers
  1. American Association for Cancer Research (5)
  2. Nature Publishing Group (4)
  3. Society of Nuclear Medicine (4)
  4. Wiley Blackwell (2)
  5. Amer Assoc Advancement Science (1)
  6. American Chemical Society (1)

More Publishers

Results (23)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • CDK9-mediated transcription elongation is required for MYC addiction in hepatocellular carcinoma
    Journal Article

    Huang, C. H.; Lujambio, A.; Zuber, J.; Tschaharganeh, D. F.; Doran, M. G.; Evans, M. J.; Kitzing, T.; Zhu, N.; de Stanchina, E.; Sawyers, C. L.; more...
    Genes and Development (2014)

    Fulltext@MSK | Save
  • Adoptively transferred TRAIL+ T cells suppress GVHD and augment antitumor activity
    Journal Article

    Ghosh, A.; Dogan, Y.; Moroz, M.; Holland, A. M.; Yim, N. L.; Rao, U. K.; Young, L. F.; Tannenbaum, D.; Masih, D.; Velardi, E.; more...
    Journal of Clinical Investigation (2013)

    Fulltext@MSK | Save
  • Annotating oncogene status in castration-resistant prostate cancer with zirconium-89-labeled radiotracers
    Meeting Abstract

    Evans, M. J.; Holland, J. P.; Ulmert, D.; Lewis, J. S.; Sawyers, C. L.
    Journal of Nuclear Medicine (2013)

    Fulltext@MSK | Save
  • A novel diagnostic strategy for PET to define the clinical significance of the magnitude of target inhibition for therapies suppressing PI3K pathway signaling in renal cell carcinoma
    Meeting Abstract

    Doran, M. G.; Cheal, S. M.; Evans, M. J.; Larson, S. M.; Sawyers, C. L.; Lewis, J. S.
    Journal of Nuclear Medicine (2013)

    Fulltext@MSK | Save
  • Imaging tumor burden in the brain with (89)Zr-transferrin
    Journal Article

    Evans, M. J.; Holland, J. P.; Rice, S. L.; Doran, M. G.; Cheal, S. M.; Campos, C.; Carlin, S. D.; Mellinghoff, I. K.; Sawyers, C. L.; Lewis, J. S.
    Journal of Nuclear Medicine (2013)

    Fulltext@MSK | Save
  • Biochemical evidence towards the existence of an oncogenic Hsp90 complex
    Meeting Abstract

    Rodina, A.; Moulick, K.; Ahn, J.; Zong, H. L.; Cerchietti, L.; DaGama, E. G.; Caldas-Lopes, E.; Beebe, K.; Perna, F.; Hatzi, K.; more...
    Cancer Research (2012)

    Fulltext@MSK | Save
  • Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90
    Meeting Abstract

    Gomes-DaGama, E. M.; Moulick, K.; Ahn, J. H.; Zong, H.; Rodina, A.; Cerchietti, L.; Lopes-Vazquez, M. E. C.; Beebe, K.; Perna, F.; Katerina, C.; more...
    Cancer Research (2012)

    Fulltext@MSK | Save
  • Annotating MYC status with (89)Zr-transferrin imaging
    Journal Article

    Holland, J. P.; Evans, M. J.; Rice, S. L.; Wongvipat, J.; Sawyers, C. L.; Lewis, J. S.
    Nature Medicine (2012)

    Fulltext@MSK | Save
  • Imaging androgen receptor signaling with a radiotracer targeting free prostate-specific antigen
    Journal Article

    Ulmert, D.; Evans, M. J.; Holland, J. P.; Rice, S. L.; Wongvipat, J.; Pettersson, K.; Abrahamsson, P. A.; Scardino, P. T.; Larson, S. M.; Lilja, H.; more...
    Cancer Discovery (2012)

    Fulltext@MSK | Save
  • Synthesis of fluorinated analogs of abiraterone, a mechanism-based inhibitor of CYP17A1 for castration resistant prostate cancer therapy
    Meeting Abstract

    Veach, D. R.; Evans, M.; Sawyers, C. L.; Larson, S. M.
    Journal of Labelled Compounds and Radiopharmaceuticals (2011)

    Fulltext@MSK | Save